Imperial College London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University of Oxford Featured PhD Programmes
University of Dundee Featured PhD Programmes
Cardiff University Featured PhD Programmes
"radiotherapy"×
10 miles

Molecular Biology (radiotherapy) PhD Projects, Programs & Scholarships

We have 10 Molecular Biology (radiotherapy) PhD Projects, Programs & Scholarships

  • "radiotherapy" ×
  • Molecular Biology×
  • clear all
Order by 
Showing 1 to 10 of 10
  HDAC inhibitors: a potential therapy for breast cancer?
  Dr C Staton, Dr B Corfe
Applications accepted all year round

Funding Type

PhD Type

Radiation resistance, due to hypoxia, remains a major cause of mortality in the treatment of breast cancer.
  MRC DiMeN Doctoral Training Partnership: Activation of Aurora Kinase A by DNA damage – understanding the signalling pathway to improve radiotherapy response
  Dr H Bryant, Prof C Eyers, Prof P Eyers
Application Deadline: 6 January 2020

Funding Type

PhD Type

Radiation is a mainstay of cancer therapy, however radioresistance is a significant challenge in the treatment of locally advanced, recurrent and metastatic cancers.
  Radiation induced oxidative DNA damage and cancer immunology in NSCLC
  Dr C Hiley, Dr S Boulton
Application Deadline: 29 November 2019

Funding Type

PhD Type

Forty percent of all patients cured of cancer have radiotherapy as part of their treatment. Lung cancer is the most common cause of cancer death in the UK and in non-small cell lung cancer (NSCLC) radiotherapy is the standard of care for patients with stage III disease.
  Pre-clinical investigations of POLQ inhibitors
  Dr G Higgins, Prof T Humphrey
Application Deadline: 10 January 2020

Funding Type

PhD Type

THE PROJECT. The aim of our research is to improve radiotherapy for cancer patients by making tumour cells more sensitive to radiation without affecting the sensitivity of normal cells.
  MRC DiMeN Doctoral Training Partnership: Harnessing Autophagy for the Clinical benefit of Oropharyngeal Squamous Cell Carcinoma
  Prof P Lovat, Dr M Robinson
Application Deadline: 6 January 2020

Funding Type

PhD Type

Oropharyngeal squamous cell carcinoma (OPSCC) accounts for 97,000 deaths annually worldwide with an increasing incidence attributed to human papillomavirus (HPV).
  MRC DiMeN Doctoral Training Partnership: Developing protein tools to target DNA damage response and repair in cancer cells
  Dr Q. Wu, Dr D Tomlinson
Application Deadline: 6 January 2020

Funding Type

PhD Type

DNA damage response (DDR) and repair play critical roles in influencing the efficiency and sensitivity of many cancer treatments.
  Identifying novel treatment options for ovarian carcinosarcoma
  Dr H Barker
Application Deadline: 31 January 2020

Funding Type

PhD Type

Location. The Walter and Eliza Hall Institute of Medical Research, University of Melbourne. Supervisors. Prof C. Scott, Dr H. Barker.
  Characterisation of DNA-protein crosslink proteolysis repair in cancer and therapy
  Prof K Ramadan, Prof B Kessler
Application Deadline: 4 December 2019

Funding Type

PhD Type

THE PROJECT. DNA-protein crosslinks (DPCs) are under-investigated DNA lesions caused by the covalent attachment of proteins to DNA.
  Targeting DNA repair to overcome cancer therapy resistance
  Prof P McHugh, Prof T Brown
Application Deadline: 4 December 2019

Funding Type

PhD Type

THE PROJECT. DNA cross-linking drugs and radiotherapy (RT) are used to treat a range of tumours including many hard-to-treat cancers (e.g.
  Characterisation of in vitro models of human salivary glands and their use in functional studies
  Dr L Bingle, Prof C Bingle
Applications accepted all year round

Funding Type

PhD Type

Saliva is produced by three pairs of major salivary glands and multiple minor glands in the lips, associated with the tongue and also with the palate.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.